Regarding TSPO-PET binding, previous studies using second-generation tracers have demonstrated significantly lower binding potential in healthy controls compared to individuals with AD (Kreisl et al., 2013; Yasuno et al., 2008, 2022). The gene discussed is TSPO; the disease is Alzheimer disease.